Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Technical Analysis

230 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is 1.59, suggesting Keros Therapeutics is a Buy.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 62.37, while Keros Therapeutics’s (KROS) share price is $56.62, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 59.13, while Keros Therapeutics’s (KROS) share price is $56.62, making it a Buy.

Keros Therapeutics (KROS) Pivot Points

Nov 15, 2024, 08:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
57.59
59.83
61.45
63.69
65.31
67.55
69.17
Fibonacci
59.83
61.30
62.22
63.69
65.16
66.08
67.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Nov 15, 2024, 08:49 PM
Period
Simple
Exponential
MA5
64.87Sell
63.39Sell
MA10
64.05Sell
63.46Sell
MA20
61.91Sell
62.37Sell
MA50
59.33Buy
59.13Buy
MA100
53.17Buy
55.96Buy
MA200
55.42Buy
54.38Buy
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 63.46, while Keros Therapeutics’s (KROS) share price is $56.62, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 55.96, while Keros Therapeutics’s (KROS) share price is $56.62, making it a Buy.
Keros Therapeutics’s (KROS) stock price is $56.62 and Keros Therapeutics’s (KROS) 50-day simple moving average is 59.33, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $56.62 and Keros Therapeutics’s (KROS) 100-day simple moving average is 53.17, creating a Buy signal.
Keros Therapeutics’s (KROS) stock price is $56.62 and Keros Therapeutics’s (KROS) 200-day simple moving average is 55.42, creating a Buy signal.

Keros Therapeutics (KROS) Technical Indicators

Nov 15, 2024, 08:49 PM
Name
Value
Implied Action
RSI (14)
46.74
Neutral
STOCH (9,6)
41.14
Neutral
STOCHRSI (14)
41.14
Neutral
MACD (12,26)
1.59
Buy
ADX (14)
27.61
Neutral
Williams %R
-77.85
Buy
CCI (14)
-15.96
Neutral
ATR (14)
2.84
-
Ultimate Oscillator
41.48
Neutral
ROC
-0.67
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 46.74, creating a Neutral signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 27.61, creating a Neutral signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -15.96, creating a Neutral signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -0.67, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Hold.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 46.74, which suggests KROS is a Neutral.
      What is KROS’s MACD?
      KROS’s MACD is 1.59, which suggests KROS is a Buy.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 64.87, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 61.91, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 59.33, which suggests KROS is a Buy.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 55.42, which suggests KROS is a Buy.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -77.85, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -15.96, which suggests KROS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis